Fig. 4From: Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillationRisk of the net adverse clinical event death by anticoagulation therapy according to the CHA2DS2-VASc score in patients with chronic kidney disease stage 5Back to article page